Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China flag China · Delayed Price · Currency is CNY
11.45
+0.02 (0.17%)
Apr 29, 2026, 3:04 PM CST

SHE:301211 Statistics

Total Valuation

SHE:301211 has a market cap or net worth of CNY 4.78 billion. The enterprise value is 3.24 billion.

Market Cap4.78B
Enterprise Value 3.24B

Important Dates

The last earnings date was Tuesday, March 31, 2026.

Earnings Date Mar 31, 2026
Ex-Dividend Date May 26, 2025

Share Statistics

SHE:301211 has 417.60 million shares outstanding. The number of shares has decreased by -4.19% in one year.

Current Share Class 417.60M
Shares Outstanding 417.60M
Shares Change (YoY) -4.19%
Shares Change (QoQ) -5.85%
Owned by Insiders (%) 14.75%
Owned by Institutions (%) 0.31%
Float 167.32M

Valuation Ratios

The trailing PE ratio is 143.13.

PE Ratio 143.13
Forward PE n/a
PS Ratio 10.42
PB Ratio 2.09
P/TBV Ratio 2.16
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 66.47, with an EV/FCF ratio of -70.95.

EV / Earnings 95.97
EV / Sales 7.07
EV / EBITDA 66.47
EV / EBIT n/a
EV / FCF -70.95

Financial Position

The company has a current ratio of 17.18, with a Debt / Equity ratio of 0.00.

Current Ratio 17.18
Quick Ratio 15.76
Debt / Equity 0.00
Debt / EBITDA 0.05
Debt / FCF -0.05
Interest Coverage 4.98

Financial Efficiency

Return on equity (ROE) is 1.47% and return on invested capital (ROIC) is 0.11%.

Return on Equity (ROE) 1.47%
Return on Assets (ROA) 0.02%
Return on Invested Capital (ROIC) 0.11%
Return on Capital Employed (ROCE) 0.04%
Weighted Average Cost of Capital (WACC) 8.35%
Revenue Per Employee 482,169
Profits Per Employee 35,507
Employee Count952
Asset Turnover 0.19
Inventory Turnover 2.81

Taxes

In the past 12 months, SHE:301211 has paid 5.21 million in taxes.

Income Tax 5.21M
Effective Tax Rate 13.35%

Stock Price Statistics

The stock price has increased by +4.41% in the last 52 weeks. The beta is 0.75, so SHE:301211's price volatility has been lower than the market average.

Beta (5Y) 0.75
52-Week Price Change +4.41%
50-Day Moving Average 12.13
200-Day Moving Average 12.88
Relative Strength Index (RSI) 38.88
Average Volume (20 Days) 4,296,537

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHE:301211 had revenue of CNY 459.02 million and earned 33.80 million in profits. Earnings per share was 0.08.

Revenue459.02M
Gross Profit 94.66M
Operating Income 891,596
Pretax Income 39.01M
Net Income 33.80M
EBITDA 47.62M
EBIT 891,596
Earnings Per Share (EPS) 0.08
Full Income Statement

Balance Sheet

The company has 1.54 billion in cash and 2.35 million in debt, with a net cash position of 1.54 billion or 3.68 per share.

Cash & Cash Equivalents 1.54B
Total Debt 2.35M
Net Cash 1.54B
Net Cash Per Share 3.68
Equity (Book Value) 2.28B
Book Value Per Share 4.95
Working Capital 1.69B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -968,981 and capital expenditures -44.75 million, giving a free cash flow of -45.72 million.

Operating Cash Flow -968,981
Capital Expenditures -44.75M
Depreciation & Amortization 46.73M
Net Borrowing -1.40M
Free Cash Flow -45.72M
FCF Per Share -0.11
Full Cash Flow Statement

Margins

Gross margin is 20.62%, with operating and profit margins of 0.19% and 7.36%.

Gross Margin 20.62%
Operating Margin 0.19%
Pretax Margin 8.50%
Profit Margin 7.36%
EBITDA Margin 10.37%
EBIT Margin 0.19%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 0.52%.

Dividend Per Share 0.06
Dividend Yield 0.52%
Dividend Growth (YoY) -47.92%
Years of Dividend Growth n/a
Payout Ratio 213.00%
Buyback Yield 4.19%
Shareholder Yield 4.72%
Earnings Yield 0.71%
FCF Yield -0.96%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 27, 2025. It was a forward split with a ratio of 1.45.

Last Split Date Aug 27, 2025
Split Type Forward
Split Ratio 1.45

Scores

Altman Z-Score n/a
Piotroski F-Score 4